window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 10, 2026

  • News
  • About Us
Contact Us

Movers & Shakers

  • Biomanufacturing,Biotech,CDMOs & Manufacturing,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    Symeres welcomes Jurgen Berendsen as CFO to support global expansion

    Symeres has appointed Jurgen Berendsen as chief financial officer, strengthening [...]

    January 14, 2026
  • Artificial Intelligence,Digital Health,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    CluePoints names Sinead Godkin CPO to scale global workforce

    CluePoints has appointed Sinead Godkin as chief people officer, strengthening [...]

    January 14, 2026
  • Biotech,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    BIA names Chris Molloy CEO to drive UK bioscience growth

    The BioIndustry Association (BIA) has appointed Chris Molloy as its [...]

    January 14, 2026
  • Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Clinical Development,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    iXCells names Steve Smith CEO to advance human iPSC preclinical services

    iXCells Biotechnologies has appointed Steve Smith as chief executive officer, [...]

    January 14, 2026
  • Clinical Development,Clinical Trials,Digital Health,Healthcare leadership,Movers & Shakers

    Qureight names Rebecca Simmons COO to lead operational scaling

    Qureight has appointed Rebecca Simmons as chief operating officer, strengthening [...]

    January 14, 2026
  • Biotech,Genetic Diseases,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics,Precision medicine

    Enhanced Genomics appoints Katerina Leftheris to board of directors

    Enhanced Genomics has appointed Katerina Leftheris to its board of [...]

    January 14, 2026
  • Biologics & Biosimilars,Biotech,Cell & Gene Therapy,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    NanoSyrinx appoints Thomas Farrell as CEO

    NanoSyrinx has appointed Thomas Farrell as chief executive officer and [...]

    January 14, 2026
  • Biotech,Clinical Development,Healthcare leadership,Movers & Shakers

    Novotech appoints Anand Tharmaratnam as CEO

    Novotech has appointed Anand Tharmaratnam as chief executive officer, following [...]

    January 14, 2026
  • Biotech,Central Nervous System,Healthcare leadership,Movers & Shakers,Neurosciences

    AstronauTx appoints Adam Rosenberg as Chair of the Board

    AstronauTx has appointed Adam Rosenberg as chair of the board, [...]

    January 14, 2026
  • Clinical Development,Clinical Trials,Digital Health,Healthcare leadership,Movers & Shakers

    Qureight appoints Steven Bishop as Chief Medical Officer

    Qureight has appointed Steven Bishop as chief medical officer, marking [...]

    January 14, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Quest Diagnostics launches flow cytometry MRD blood test for myeloma to support ultrasensitive monitoring
    Categories: Diagnostics, Hematology, Oncology, Real world evidence
  • Levicept appoints James Sandy as chief development officer to advance LEVI-04 for osteoarthritis
    Categories: Biologics & Biosimilars, Clinical Development, Clinical Trials, Drug Development, Movers & Shakers, Orthapaedics, Rare Diseases
  • Cereno Scientific completes expanded access program milestone for CS1 in pulmonary arterial hypertension
    Categories: Cardiovascular diseases, Clinical Trials, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top